134 related articles for article (PubMed ID: 9292937)
1. Plasma androsterone/epiandrosterone sulfates as markers of 5 alpha-reductase activity: effect of finasteride in normal men.
Lewis JG; George PM; Elder PA
Steroids; 1997; 62(8-9):632-5. PubMed ID: 9292937
[TBL] [Abstract][Full Text] [Related]
2. The effect of isoflavone extract ingestion, as Trinovin, on plasma steroids in normal men.
Lewis JG; Morris JC; Clark BM; Elder PA
Steroids; 2002 Jan; 67(1):25-9. PubMed ID: 11728518
[TBL] [Abstract][Full Text] [Related]
3. C19 and C21 5 beta/5 alpha metabolite ratios in subjects treated with the 5 alpha-reductase inhibitor finasteride: comparison of male pseudohermaphrodites with inherited 5 alpha-reductase deficiency.
Imperato-McGinley J; Shackleton C; Orlic S; Stoner E
J Clin Endocrinol Metab; 1990 Mar; 70(3):777-82. PubMed ID: 1689740
[TBL] [Abstract][Full Text] [Related]
4. Effect of finasteride on serum levels of androstenedione, testosterone and their 5α-reduced metabolites in men at risk for prostate cancer.
Stanczyk FZ; Azen CG; Pike MC
J Steroid Biochem Mol Biol; 2013 Nov; 138():10-6. PubMed ID: 23474436
[TBL] [Abstract][Full Text] [Related]
5. Production and characterization of monoclonal antibodies to dehydroepiandrosterone sulfate: application to direct enzyme-linked immunosorbent assays of dehydroepiandrosterone sulfate and androsterone/epiandrosterone sulfates in plasma.
Lewis JG; Bason LM; Elder PA
Steroids; 1996 Dec; 61(12):682-7. PubMed ID: 8987136
[TBL] [Abstract][Full Text] [Related]
6. Effects of the anti-androgen finasteride on the modulatory actions of oestradiol on androgen metabolism by human gingival fibroblasts.
Tilakaratne A; Soory M
Arch Oral Biol; 2001 Feb; 46(2):109-15. PubMed ID: 11163318
[TBL] [Abstract][Full Text] [Related]
7. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
8. Differential effect of finasteride on the tissue androgen concentrations in benign prostatic hyperplasia.
Habib FK; Ross M; Tate R; Chisholm GD
Clin Endocrinol (Oxf); 1997 Feb; 46(2):137-44. PubMed ID: 9135694
[TBL] [Abstract][Full Text] [Related]
9. Androgen sulfate and glucuronide conjugates in nonhirsute and hirsute women with polycystic ovarian syndrome.
Matteri RK; Stanczyk FZ; Gentzschein EE; Delgado C; Lobo RA
Am J Obstet Gynecol; 1989 Dec; 161(6 Pt 1):1704-9. PubMed ID: 2532471
[TBL] [Abstract][Full Text] [Related]
10. Effect of finasteride on adrenal steroidogenesis in men.
Rittmaster RS; Antonian L; New MI; Stoner E
J Androl; 1994; 15(4):298-301. PubMed ID: 7982796
[TBL] [Abstract][Full Text] [Related]
11. Androsterone sulfate: physiology and clinical significance in hirsute women.
Zwicker H; Rittmaster RS
J Clin Endocrinol Metab; 1993 Jan; 76(1):112-6. PubMed ID: 8380602
[TBL] [Abstract][Full Text] [Related]
12. Effects of the 5 alpha-reductase inhibitor finasteride on serum levels of gonadal, adrenal, and hypophyseal hormones and its clinical significance: a prospective clinical study.
Uygur MC; Arik AI; Altuğ U; Erol D
Steroids; 1998 Apr; 63(4):208-13. PubMed ID: 9589555
[TBL] [Abstract][Full Text] [Related]
13. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
Fruzzetti F; de Lorenzo D; Parrini D; Ricci C
J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369
[TBL] [Abstract][Full Text] [Related]
14. Effect of Ginkgo biloba extract on plasma steroid concentrations in healthy volunteers: a pilot study.
Markowitz JS; DeVane CL; Lewis JG; Chavin KD; Wang JS; Donovan JL
Pharmacotherapy; 2005 Oct; 25(10):1337-40. PubMed ID: 16185177
[TBL] [Abstract][Full Text] [Related]
15. Assessment of 5 alpha-reductase activity in hirsute women: comparison of serum androstanediol glucuronide with urinary androsterone and aetiocholanolone excretion.
Gilad S; Chayen R; Tordjman K; Kisch E; Stern N
Clin Endocrinol (Oxf); 1994 Apr; 40(4):459-64. PubMed ID: 8187312
[TBL] [Abstract][Full Text] [Related]
16. Panhypopituitarism as a model to study the metabolism of dehydroepiandrosterone (DHEA) in humans.
Young J; Couzinet B; Nahoul K; Brailly S; Chanson P; Baulieu EE; Schaison G
J Clin Endocrinol Metab; 1997 Aug; 82(8):2578-85. PubMed ID: 9253337
[TBL] [Abstract][Full Text] [Related]
17. The benefits of finasteride for hirsute women with polycystic ovary syndrome or idiopathic hirsutism.
Lakryc EM; Motta EL; Soares JM; Haidar MA; de Lima GR; Baracat EC
Gynecol Endocrinol; 2003 Feb; 17(1):57-63. PubMed ID: 12724020
[TBL] [Abstract][Full Text] [Related]
18. Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride.
Duskova M; Hill M; Starka L
Endocr Regul; 2010 Jan; 44(1):3-8. PubMed ID: 20151762
[TBL] [Abstract][Full Text] [Related]
19. Dihydrotestosterone and the concept of 5alpha-reductase inhibition in human benign prostatic hyperplasia.
Bartsch G; Rittmaster RS; Klocker H
Eur Urol; 2000 Apr; 37(4):367-80. PubMed ID: 10765065
[TBL] [Abstract][Full Text] [Related]
20. Androgen metabolism in the prostate of the finasteride-treated, adult rat: a possible explanation for the differential action of testosterone and 5 alpha-dihydrotestosterone during development of the male urogenital tract.
George FW
Endocrinology; 1997 Mar; 138(3):871-7. PubMed ID: 9048585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
